Your browser is no longer supported. Please, upgrade your browser.
Settings
STIM Neuronetics, Inc. daily Stock Chart
STIM [NASD]
Neuronetics, Inc.
Index- P/E- EPS (ttm)-1.58 Insider Own7.20% Shs Outstand20.43M Perf Week-11.32%
Market Cap28.81M Forward P/E- EPS next Y-1.22 Insider Trans12.42% Shs Float15.87M Perf Month-47.97%
Income-29.00M PEG- EPS next Q-0.48 Inst Own79.60% Short Float2.91% Perf Quarter-68.67%
Sales62.70M P/S0.46 EPS this Y41.30% Inst Trans0.01% Short Ratio1.54 Perf Half Y-83.94%
Book/sh2.57 P/B0.55 EPS next Y18.70% ROA-27.10% Target Price8.25 Perf Year-91.77%
Cash/sh3.71 P/C0.38 EPS next 5Y- ROE-51.10% 52W Range1.25 - 17.76 Perf YTD-68.60%
Dividend- P/FCF- EPS past 5Y- ROI-34.00% 52W High-92.06% Beta-
Dividend %- Quick Ratio3.10 Sales past 5Y- Gross Margin75.40% 52W Low12.80% ATR0.37
Employees235 Current Ratio3.20 Sales Q/Q11.50% Oper. Margin-42.90% RSI (14)35.16 Volatility23.82% 24.46%
OptionableNo Debt/Eq0.65 EPS Q/Q-16.50% Profit Margin-46.40% Rel Volume0.68 Prev Close1.54
ShortableYes LT Debt/Eq0.42 EarningsMar 03 BMO Payout- Avg Volume299.02K Price1.41
Recom- SMA20-20.61% SMA50-48.38% SMA200-79.71% Volume202,252 Change-8.44%
Feb-06-20Initiated BTIG Research Buy $11
Jul-24-18Initiated Canaccord Genuity Buy
Mar-30-20 07:30AM  Neuronetics Recognized as 2020 Top Neurology Device Provider GlobeNewswire +28.30%
Mar-16-20 07:30AM  Neuronetics® Hits Major Milestones with More Than 2.5 Million Treatments and 1,000 Installations of Its NeuroStar® Advanced Therapy System GlobeNewswire -6.73%
Mar-13-20 01:18PM  Stephen Furlong Is The Chief Financial Officer of Neuronetics, Inc. (NASDAQ:STIM) And They Just Spent US$50k On Shares Simply Wall St. -5.02%
Mar-06-20 10:15AM  Malvern medical device company CEO departs; stock skyrockets American City Business Journals
08:49AM  The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study Benzinga
07:30AM  FDA Grants NeuroStar® Advanced Therapy System Breakthrough Device Designation to Treat Bipolar Depression GlobeNewswire
Mar-05-20 12:54PM  Neuronetics, Inc. announces Chris Thatcher will step down as President and CEO GlobeNewswire
Mar-03-20 07:30AM  Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates Zacks -15.65%
06:00AM  Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results GlobeNewswire
Feb-25-20 12:30PM  Earnings Preview: Neuronetics (STIM) Q4 Earnings Expected to Decline Zacks
Feb-18-20 08:00AM  Neuronetics to Report Fourth Quarter and Fiscal Year 2019 Financial and Operating Results and Host Conference Call GlobeNewswire
Feb-13-20 07:00AM  GE Slashed Its Investment in This Slumping Medical-Tech Stock Barrons.com
Feb-12-20 04:05PM  Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO GlobeNewswire -5.56%
Jan-21-20 07:30AM  Neuronetics Appoints Andrew Macan As Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary GlobeNewswire
Jan-16-20 10:14AM  If You Had Bought Neuronetics (NASDAQ:STIM) Stock A Year Ago, You'd Be Sitting On A 72% Loss, Today Simply Wall St.
Dec-20-19 05:47PM  Neuronetics, Inc. (STIM) Is Burning These Hedge Funds Insider Monkey
Nov-25-19 07:30AM  Neuronetics to Present at the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-21-19 08:00AM  Daré Bioscience Closes Previously Announced Acquisition of Microchips Biotech with a First-in-Class Wireless, User-Controlled Drug Delivery Platform GlobeNewswire
Nov-07-19 07:30AM  Neuronetics® to Present New Depression Research at 15th Annual Neuroscience Education Institute Congress PR Newswire
Nov-05-19 08:45AM  Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates Zacks -39.13%
07:30AM  Neuronetics Reports Third Quarter 2019 Financial and Operating Results GlobeNewswire
Nov-01-19 07:30AM  Neuronetics® Announces Appointment of Sheryl Conley to its Board of Directors GlobeNewswire
Oct-30-19 01:53PM  How Much Are Neuronetics, Inc. (NASDAQ:STIM) Insiders Taking Off The Table? Simply Wall St.
Oct-29-19 10:33AM  Analysts Estimate Neuronetics (STIM) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-28-19 07:30AM  Neuronetics® and Success TMS Partner to Increase Patient Access to Leading Depression Treatment, NeuroStar® Advanced Therapy PR Newswire
Oct-22-19 07:30AM  Neuronetics to Report Third Quarter 2019 Financial and Operating Results and Host Conference Call GlobeNewswire
Oct-21-19 07:30AM  Neuronetics CEO Chris Thatcher to Ring Nasdaq Closing Bell on October 22 in Honor of National Depression Awareness Month PR Newswire
Oct-03-19 07:30AM  Neuronetics® Unveils Promising New Depression Research Data at Psych Congress PR Newswire
Oct-01-19 07:30AM  Neuronetics® Honors Depression Conquerors For National Depression Awareness Month PR Newswire
Sep-04-19 07:30AM  Neuronetics® Announces Greenbrook® TMS Installation Milestone for NeuroStar® Advanced Therapy System PR Newswire
Aug-27-19 01:15PM  Is Neuronetics (NASDAQ:STIM) Using Debt In A Risky Way? Simply Wall St.
Aug-19-19 07:30AM  Researchers at USU Unveil Neuronetics®-supported Clinical Research for PTSD and Traumatic Brain Injury at the Military Health System Research Symposium PR Newswire
Aug-07-19 09:24PM  Neuronetics, Inc. (STIM) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 08:45AM  Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:30AM  Neuronetics Reports Second Quarter 2019 Financial and Operating Results GlobeNewswire
Aug-01-19 07:30AM  Neuronetics® Announces First TMS Patient Treated Under New Japan Reimbursement Policy PR Newswire
Jul-29-19 07:30AM  Neuronetics® Launches TrakStar® Plus Patient Data Management System to Maximize Physician Time with Patients PR Newswire
Jul-25-19 04:30PM  Neuronetics to Present at the 39th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-23-19 08:00AM  Neuronetics to Report Second Quarter 2019 Financial and Operating Results and Host Conference Call GlobeNewswire
Jul-17-19 04:19PM  These 4 Medical Stocks Could Benefit From J&J Earnings Here's Why Investor's Business Daily
Jul-08-19 07:30AM  NeuroStar® Patient Outcomes Registry Has Now Surpassed 3,000 Evaluable Patients, Making It The World's Largest in Major Depressive Disorder PR Newswire
Jul-03-19 07:31AM  The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief Benzinga
Jul-02-19 09:03PM  Shareholder Rights Law Firm Johnson Fistel Launches Investigations PR Newswire
04:30PM  Neuronetics Appoints Stephen Furlong as Chief Financial Officer GlobeNewswire
Jun-27-19 07:15AM  Some Neuronetics (NASDAQ:STIM) Shareholders Have Copped A Big 61% Share Price Drop Simply Wall St.
Jun-05-19 07:30AM  Neuronetics to Present at the JMP Life Sciences Conference GlobeNewswire -5.41%
Jun-03-19 07:30AM  NeuroStar® Advanced Therapy Receives National Reimbursement Listing in Japan GlobeNewswire
May-28-19 09:43PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Neuronetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
12:09PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Neuronetics, Inc. Investors (STIM) Business Wire
May-23-19 04:30PM  Neuronetics to Present at the William Blair 39th Annual Growth Stock Conference GlobeNewswire
May-15-19 05:38PM  General Electric Co Buys Westinghouse Air Brake Technologies Corp, Neuronetics Inc GuruFocus.com
May-14-19 07:30AM  NeuroStar® Advanced Therapy Survey Finds Majority of Americans Don't Feel Very Equipped to Discuss Depression With Loved Ones PR Newswire
May-08-19 04:24PM  Neuronetics, Inc. (STIM) Q1 2019 Earnings Call Transcript Motley Fool
May-07-19 07:41AM  Neuronetics: 1Q Earnings Snapshot Associated Press -7.94%
07:30AM  Neuronetics Reports First Quarter 2019 Financial and Operating Results GlobeNewswire
Apr-26-19 11:49AM  Is Neuronetics, Inc. (NASDAQ:STIM) A Financially Sound Company? Simply Wall St. +10.08%
Apr-23-19 08:00AM  Neuronetics to Report First Quarter 2019 Financial and Operating Results and Host Conference Call GlobeNewswire
Mar-27-19 04:15PM  NeuroStar® Advanced Therapy to Receive Reimbursement Approval in Japan GlobeNewswire
Mar-26-19 08:00AM  Neuronetics to Present at the 18th Annual Needham & Company Healthcare Conference GlobeNewswire
Mar-25-19 05:43PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Neuronetics, Inc. Investors (STIM) GlobeNewswire
Mar-21-19 08:00AM  Neuronetics, Inc. Celebrates Dr. Charles Epstein's Contributions to Magnetic Stimulation Research PR Newswire
Mar-05-19 12:07PM  Neuronetics, Inc. (STIM) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:00AM  Neuronetics Reports Fourth Quarter and Full Year 2018 Financial and Operating Results GlobeNewswire
06:30AM  Neuronetics, Inc. to Host Earnings Call ACCESSWIRE
Feb-21-19 08:00AM  NeuroStar® Advanced Therapy to Host Industry Best Practices Symposia at Clinical TMS Society Annual Meeting PR Newswire
Feb-19-19 04:15PM  Neuronetics to Report Fourth Quarter and Fiscal Year 2018 Financial and Operating Results and Host Conference Call GlobeNewswire
Feb-15-19 08:00AM  Neuronetics, Inc. Announces Appointment of Dr. Cheryl R. Blanchard to its Board of Directors GlobeNewswire
Jan-07-19 08:00AM  Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue GlobeNewswire -8.13%
Dec-20-18 09:35AM  Who Has Been Buying Neuronetics, Inc. (NASDAQ:STIM) Shares? Simply Wall St.
Nov-27-18 06:29PM  At FDA, a new goal, then a push for speedy device reviews Associated Press
Nov-15-18 08:00AM  Neuronetics to Present at the 30th Annual Piper Jaffray Healthcare Conference GlobeNewswire -5.54%
Nov-13-18 08:00AM  NeuroStar® Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment PR Newswire
Nov-06-18 07:21AM  Neuronetics: 3Q Earnings Snapshot Associated Press
07:00AM  Neuronetics Reports Third Quarter 2018 Financial and Operating Results GlobeNewswire
Oct-23-18 08:00AM  Neuronetics to Report Third Quarter 2018 Financial Results and Host Conference Call GlobeNewswire
Oct-18-18 10:52AM  PhaseBio goes public in downsized $46M IPO American City Business Journals
Oct-01-18 08:00AM  Neuronetics to be Added to the Russell 2000®, 3000® and Microcap® Indexes GlobeNewswire
Aug-14-18 07:00AM  Neuronetics Reports Second Quarter 2018 Financial and Operating Results GlobeNewswire
Jul-31-18 06:00AM  Neuronetics, Inc. to Report Second Quarter 2018 Financial Results and Host Conference Call GlobeNewswire
Jul-27-18 07:45AM  Breakfast Technical Briefing on TrovaGene and Three Other Additional Medical Research Stocks ACCESSWIRE
Jul-24-18 07:44AM  [$$] Gormley's Take: Public Markets' Embrace of Health Care Extends Beyond Biotech The Wall Street Journal
Jul-23-18 04:58PM  Neuronetics Wins A Sell-Side Bull With Pill-Free Depression Treatment Benzinga
Jul-11-18 06:56AM  IPO boom has opened the window for some scary companies MarketWatch
Jul-02-18 04:48PM  Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Closing of Initial Public Offering and the Exercise in Full of the Underwriters Option to Purchase Additional Shares GlobeNewswire
Jun-28-18 07:00AM  Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Pricing of Initial Public Offering GlobeNewswire
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States, Japan, and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrist customers. Neuronetics, Inc. was founded in 2003 and is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farley Brian EDirectorMar 13Buy2.2840,00091,200217,606Mar 16 04:49 PM
Farley Brian EDirectorMar 12Buy2.1810,00021,800177,606Mar 16 04:49 PM
Guthrie DanielChief Commercial OfficerMar 12Buy2.365,00011,800146,855Mar 13 04:26 PM
Furlong StephenVP and CFOMar 10Buy2.0025,00050,000274,184Mar 11 05:31 PM
MACAN WILLIAM ANDREWSr. VP, GC, CCO and SecretaryMar 10Buy2.005,00010,000182,399Mar 11 05:28 PM
Thatcher ChristopherPresident and CEOMar 04Option Exercise0.8720,00017,400249,811Mar 04 08:16 PM
Harper GregoryVP of R&D, Ops. and Prod. Dev.Dec 16Buy4.4010,00044,00075,480Dec 18 04:51 PM
Guthrie DanielChief Commercial OfficerDec 02Buy4.282,50010,70049,074Dec 03 04:10 PM
CAMPE STEPHEN MDirectorNov 25Buy4.232,50010,57529,410Nov 26 06:41 AM
CAMPE STEPHEN MDirectorNov 22Buy4.269,50040,47026,910Nov 26 06:41 AM
Farley Brian EDirectorNov 18Buy4.2711,00046,970147,606Nov 18 07:45 PM
Furlong StephenCFO and SecretaryNov 15Buy4.4922,959103,08688,934Nov 19 04:40 PM
Farley Brian EDirectorNov 14Buy4.6019,00087,400136,606Nov 18 07:45 PM